Delivery Order SPE2DB22D9207-SPE2DB24FH5AH
Award Date
5/20/24
Potential Completion Date
6/11/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $32,882.72 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) valued at $499,999,999. The delivery order is for STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The IDC with the DLA, under the SPE2DB program, allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,049.84 firm fixed-price delivery order is for the supply of 130 mg/26 ml vials of the drug Stelara, with a performance period through April 21, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of 130 mg/26 ml vials of the drug Stelara. The $3,730.56 firm fixed-price delivery order was awarded on October 23, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 14, 2024. The award is not associated with any set-aside designations. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of STELARA 130 MG/26 ML VIAL 26ML. The contract has a ceiling value of $4,974.08 and an ultimate completion date of July 25, 2024. The contract is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, with no set-aside designation. This contract award is part of a larger indefinite delivery contract (IDC) valued...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm-fixed price delivery order with a ceiling value of $3,589.70 issued under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued up to $499,999,999, allows the DLA to procure a comprehensive range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to fulfill the recurring medical supply needs of military health...
This federal contract award is a delivery order worth $8,220.68 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price award for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through March 17, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products. The award, valued at $4,974.08, is for the delivery of 4564244572 - STELARA 130 MG/26 ML VIAL 26ML. The contract has a firm fixed-price pricing type and an ultimate completion date of April 26, 2024. DMS Pharmaceutical Group Inc. is the prime contractor and holds an Indefinite Delivery Vehicle (IDV) contract,...
This federal contract award is a delivery order valued at $4,974.08, issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract provides for the delivery of STELARA 130 MG/26 ML VIAL 26ML, a biologic medication. The order is placed under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,787.38, is for the delivery of STELARA 130 MG/26 ML VIAL 26ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Stelara 130mg/26ml pharmaceutical product, with a performance period through December 13, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...